Everolimus-Induced Immune Effects after Heart Transplantation: A Possible Tool for Clinicians to Monitor Patients at Risk for Transplant Rejection

Background: Patients treated with an inhibitor of the mechanistic target of rapamycin (mTORI) in a calcineurin inhibitor (CNI)-free immunosuppressive regimen after heart transplantation (HTx) show a higher risk for transplant rejection. We developed an immunological monitoring tool that may improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaeske, Kristin, Lehmann, Sven, Palitzsch, Robert, Büttner, Petra, Barten, Markus J., Jawad, Khalil, Eifert, Sandra, Saeed, Diyar, Borger, Michael A., Dieterlen, Maja-Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703808/
https://www.ncbi.nlm.nih.gov/pubmed/34947904
http://dx.doi.org/10.3390/life11121373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703808/
https://www.ncbi.nlm.nih.gov/pubmed/34947904
http://dx.doi.org/10.3390/life11121373

Ejemplares similares